AGP Executive Report
Last update: 24 minutes agoCancer R&D Deal: HUTCHMED struck an exclusive licensing deal with GSK for HMPL-A830, a KRAS-EGFR antibody-targeted therapy conjugate, with up to $1.295B in milestones and royalties as early trials target colorectal, pancreatic, and lung cancers. Alzheimer’s Update: China approved LEQEMBI (lecanemab) for early Alzheimer’s as an initiation treatment, adding momentum to subcutaneous options. AI Transparency: Anthropic launched a browser-based Claude Content Checker that verifies whether a file carries Claude “content credentials,” while still not proving whether Claude actually created it. Public Health & Behavior: A review in Addiction finds controlled breathing can modestly cut cravings across substances. Cardio-Oncology: A JAMA Internal Medicine trial links routine cardiology referral and risk-factor management to better outcomes for non-metastatic prostate cancer patients on hormone therapy. Conservation From Space: Researchers used satellite radar to track emperor penguins through the Antarctic winter for the first time, aiming to improve protection as sea ice shifts. Cybersecurity AI: South Korea selected a Naver Cloud-led consortium to build a sovereign cybersecurity foundation model, backed by major GPU support. Science Capacity Building: India’s BODH program tackles the gap between doing research and leading labs, focusing on mentoring and team-building.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
